Search results for "position"

showing 10 items of 6771 documents

From Ecology to Biotechnology, Study of the Defense Strategies of Algae and Halophytes (from Trapani Saltworks, NW Sicily) with a Focus on Antioxidan…

2019

This study aimed at the characterization of the antioxidant power of polyphenol extracts (PE) obtained from the algae Cystoseira foeniculacea (CYS) (Phaeophyta) and from the halophyte Halocnemum strobilaceum (HAL), growing in the solar saltworks of western Sicily (Italy), and at the evaluation of their anti-microfouling properties, in order to correlate these activities to defense strategies in extreme environmental conditions. The antioxidant properties were assessed in the PE based on the total antioxidant activity test and the reducing power test

0301 basic medicineDPPH[CHIM.THER]Chemical Sciences/Medicinal Chemistry<i>Cystoseira foeniculacea</i>010501 environmental sciences01 natural sciencesAntioxidantsAnti-oxidantlcsh:Chemistrychemistry.chemical_compoundcrude extractsMarine bacteriophageAnti-Infective Agentslipid oxidationbiodimarCystoseira foeniculacea<i>Halocnemum strobilaceum</i>brown algaFood scienceGallic acidSicilylcsh:QH301-705.5SpectroscopyEcologybiologyanti-microbialmarine-bacteriaantifoulingHalocnemum strobilaceumSalt-Tolerant PlantsGeneral MedicineClosteriumComputer Science Applicationsseaweedscystoseiraradical-scavenging activityBiotechnologyMicrobial Sensitivity TestsPhaeophytaArticleCatalysisInorganic Chemistry03 medical and health sciencesantifouling activitiesPicratesAlgaeLipid oxidationDefense14. Life underwaterPhysical and Theoretical ChemistryMolecular BiologyShellfishpolyphenols0105 earth and related environmental sciencesBacteriaACLBiphenyl CompoundsOrganic Chemistrybiology.organism_classificationdefenses030104 developmental biologychemistrylcsh:Biology (General)lcsh:QD1-99913. Climate actionPolyphenolanti-oxidantsseasonal-variation[SDE.BE]Environmental Sciences/Biodiversity and Ecologyphenolic compositionInternational Journal of Molecular Sciences
researchProduct

Second medical opinion in oncological setting

2021

Oncological patients increasingly require second medical opinions to feel more likely confident with their oncologists and treatments, although this could lead to wrong opinions and delay in the start of treatments. Second opinions can be required also by physicians to obtain advices, especially in case of rare tumors. The request of new opinions is documented in radiology and pathology settings too, with not negligible discrepancy rate. Conversely, the role in general medical/surgical conditions has not been well established. Literature is poor of studies relative to second opinions or they are more focused on patient's motivations. For these reasons, AIOM (Italian Association of Medical O…

0301 basic medicineDecalogueEthicsmedicine.medical_specialtyMeetingbusiness.industryFoundation (evidence)HematologyMedical Oncology03 medical and health sciences030104 developmental biology0302 clinical medicineOncologyItalySecond medical opinions030220 oncology & carcinogenesisFamily medicinePhysiciansmedicinePosition paperHumansAIOM; Decalogue; Ethics; Meeting; Second medical opinions; Humans; Italy; Referral and Consultation; Medical Oncology; PhysiciansbusinessReferral and ConsultationAIOM
researchProduct

Contribution of allelic imbalance to colorectal cancer

2018

Point mutations in cancer have been extensively studied but chromosomal gains and losses have been more challenging to interpret due to their unspecific nature. Here we examine high-resolution allelic imbalance (AI) landscape in 1699 colorectal cancers, 256 of which have been whole-genome sequenced (WGSed). The imbalances pinpoint 38 genes as plausible AI targets based on previous knowledge. Unbiased CRISPR-Cas9 knockout and activation screens identified in total 79 genes within AI peaks regulating cell growth. Genetic and functional data implicate loss of TP53 as a sufficient driver of AI. The WGS highlights an influence of copy number aberrations on the rate of detected somatic point muta…

0301 basic medicineDenmarkLoss of HeterozygosityGeneral Physics and AstronomyAllelic ImbalanceLoss of heterozygosityGenotypeddc:576.5RNA Small Interferinglcsh:ScienceRNA Small Interfering/geneticsGeneticsMultidisciplinaryQGenomicsPhenotype3. Good healthGENOMEPhenotypesyöpägeenitAllelic ImbalanceTumor Suppressor Protein p53/geneticsColorectal NeoplasmsChromosomes Human Pair 8GENESDNA Copy Number VariationsGenotypeScienceTranscription Factors/geneticsGenomicscolorectal cancerBiologyArticleGeneral Biochemistry Genetics and Molecular BiologyProto-Oncogene Proteins p21(ras)Proto-Oncogene Proteins p21(ras)/genetics03 medical and health sciencesmedicineHumansPoint MutationGenetic Predisposition to DiseaseGenepaksusuolisyöpäChromosome AberrationsWhole Genome SequencingHUMAN-COLONGene Expression ProfilingPoint mutationCancerGeneral Chemistrymedicine.diseaseColorectal Neoplasms/geneticsENHANCERS030104 developmental biologyCELLSlcsh:Q3111 BiomedicineTumor Suppressor Protein p53CRISPR-Cas SystemsmutaatiotTranscription FactorsMicrosatellite Repeats
researchProduct

A genome-wide association meta-analysis of diarrhoeal disease in young children identifies FUT2 locus and provides plausible biological pathways

2016

More than a million childhood diarrhoeal episodes occur worldwide each year, and in developed countries a considerable part of them are caused by viral infections. In this study, we aimed to search for genetic variants associated with diarrhoeal disease in young children by meta-analyzing genome-wide association studies, and to elucidate plausible biological mechanisms. The study was conducted in the context of the Early Genetics and Lifecourse Epidemiology (EAGLE) consortium. Data about diarrhoeal disease in two time windows (around 1 year of age and around 2 years of age) was obtained via parental questionnaires, doctor interviews or medical records. Standard quality control and statistic…

0301 basic medicineDiarrheaMalemedicine.medical_specialtyGenotypePopulationGenome-wide association studyBiologymedicine.disease_causePolymorphism Single Nucleotide03 medical and health sciences0302 clinical medicineRotavirusEpidemiologyGeneticsmedicineHumansGenetic Predisposition to Disease030212 general & internal medicine1000 Genomes ProjectAlleleeducationMolecular BiologyGenetics (clinical)AllelesGenetic associationGeneticseducation.field_of_studyAssociation Studies ArticlesInfantGeneral MedicineFucosyltransferases3. Good health030104 developmental biologyChild PreschoolImmunologyFemaleImputation (genetics)Genome-Wide Association Study
researchProduct

Drugs Polypharmacology by in Silico Methods: New Opportunities in Drug Discovery

2016

Background Polypharmacology, defined as the modulation of multiple proteins rather than a single target to achieve a desired therapeutic effect, has been gaining increasing attention since 1990s, when industries had to withdraw several drugs due to their adverse effects, leading to permanent injuries or death, with multi-billiondollar legal damages. Therefore, if up to then the "one drug one target" paradigm had seen many researchers interest focused on the identification of selective drugs, with the strong expectation to avoid adverse drug reactions (ADRs), very recently new research strategies resulted more appealing even as attempts to overcome the decline in productivity of the drug dis…

0301 basic medicineDrugPolypharmacologymedia_common.quotation_subjectIn silicoNanotechnology03 medical and health sciencesBiological and chemical databases computational methods Drugs multitarget activity polypharmacology repurposingDrug DiscoveryMedicineHumansComputer SimulationPolypharmacologyRepurposingmedia_commonPharmacologyMolecular Structurebusiness.industryDrug discoveryDrug repositioningIdentification (information)030104 developmental biologyRisk analysis (engineering)businessChemical databaseSoftware
researchProduct

Myotonic dystrophy type 1 drug development: A pipeline toward the market

2021

Highlights • Myotonic dystrophy, a neuromuscular disease, affects at least around half a million people worldwide. • Close to two dozen preclinical and clinical drug development programs active. • Drugs encompass new chemical entities, repurposing, oligonucleotide, and gene therapy. • Tideglusib, mexiletine, and metformin are close to reaching marketing authorization.

0301 basic medicineDrugmedia_common.quotation_subjectMyotonic dystrophyDiseaseBioinformaticsMarketing authorizationMyotonic dystrophy03 medical and health sciences0302 clinical medicineGene therapyDrug DevelopmentDrug DiscoveryMedicineAnimalsHumansAntisense oligonucleotideRepurposingmedia_commonPharmacologybusiness.industryRepurposing drugmedicine.diseaseClinical trialClinical trialDrug repositioning030104 developmental biologyDrug development030220 oncology & carcinogenesisbusinessPost-Screen (Grey)Drug Discovery Today
researchProduct

Mixed topological semimetals driven by orbital complexity in two-dimensional ferromagnets

2018

The concepts of Weyl fermions and topological semimetals emerging in three-dimensional momentum space are extensively explored owing to the vast variety of exotic properties that they give rise to. On the other hand, very little is known about semimetallic states emerging in two-dimensional magnetic materials, which present the foundation for both present and future information technology. Here, we demonstrate that including the magnetization direction into the topological analysis allows for a natural classification of topological semimetallic states that manifest in two-dimensional ferromagnets as a result of the interplay between spin-orbit and exchange interactions. We explore the emerg…

0301 basic medicineElectronic properties and materialsMagnetismScienceFOS: Physical sciencesGeneral Physics and AstronomyPosition and momentum space02 engineering and technologyTopologyArticleGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesMagnetizationMagnetic properties and materialsMesoscale and Nanoscale Physics (cond-mat.mes-hall)Topological insulatorslcsh:SciencePhysicsCondensed Matter - Materials ScienceMultidisciplinaryCondensed Matter - Mesoscale and Nanoscale PhysicsQMaterials Science (cond-mat.mtrl-sci)General ChemistryFermion021001 nanoscience & nanotechnologySemimetal030104 developmental biologyDomain wall (magnetism)FerromagnetismTopological insulatorFerromagnetismlcsh:QCondensed Matter::Strongly Correlated Electronsddc:5000210 nano-technologyNature Communications
researchProduct

Bioequivalence decision for nanoparticular iron complex drugs for parenteral administration based on their disposition

2017

Although parenteral iron products have been established to medicinal use decades before, their structure and pharmacokinetic properties are not fully characterized yet. With its' second reflection paper on intravenous iron-based nano-colloidal products (EMA/CHMP/SWP/620008/2012) the European Medicine Agency provided an extensive catalogue of methods for quality, non-clinical and pharmacokinetic studies for the comparison of nano-sized iron products to an originator (EMA, 2015). For iron distribution studies, the reflection paper assumed the use of rodents. In our tests, we used a turkey fetus model to investigate time dependent tissue concentrations in pharmacological and toxicological rele…

0301 basic medicineEmbryo NonmammalianTissue concentrationsTurkeyAmylopectinDose dependenceBioequivalencePharmacologyKidneyToxicologyFerric CompoundsGlucaric Acid03 medical and health sciences0302 clinical medicinePharmacokineticsAnimalsDistribution (pharmacology)MedicineIron complexMaltoseFerric Oxide Saccharatedbusiness.industryMyocardiumGeneral MedicineDisposition030104 developmental biologyLiverTherapeutic Equivalency030220 oncology & carcinogenesisModels AnimalNanoparticlesIron-Dextran ComplexbusinessParenteral ironRegulatory Toxicology and Pharmacology
researchProduct

A TRAPPC6B splicing variant associates to restless legs syndrome

2016

Abstract INTRODUCTION: RLS is a common movement disorders with a strong genetic component in its pathophysiology, but, up to now, no causative mutation has been reported. METHODS: We re-evaluated the previously described RLS2 family by exome sequencing. RESULTS: We identified fifteen variations in the 14q critical region. The c.485G &gt; A transition of the TRAPPC6B gene segregates with the RLS2 haplotype, is absent in 200 local controls and is extremely rare in 12988 exomes from the Exome Variant Server (EVS). This variant alters a splicing site and hampers the normal transcript processing by promoting exon 3-skipping as demonstrated by minigene transfection and by patient transcripts. CON…

0301 basic medicineExome sequencingMaleVesicular Transport ProteinsLocus (genetics)VariationGene mutationBiologySplicingTransfection03 medical and health sciencesExonGene FrequencyRLSRestless Legs SyndromeAnimalsHumansGenetic Predisposition to DiseaseRNA MessengerRestless legs syndromeExomeExome sequencingMovement disorderCells CulturedGeneticsChromosomes Human Pair 14Family HealthSleep disorderHaplotypeExonsRats030104 developmental biologyAuthors report no disclosureNeurologyHaplotypesRNA splicingMutationFemaleNeurology (clinical)Geriatrics and GerontologyNeurological diseaseMinigene
researchProduct

Alignment-free sequence comparison using absent words

2018

Sequence comparison is a prerequisite to virtually all comparative genomic analyses. It is often realised by sequence alignment techniques, which are computationally expensive. This has led to increased research into alignment-free techniques, which are based on measures referring to the composition of sequences in terms of their constituent patterns. These measures, such as $q$-gram distance, are usually computed in time linear with respect to the length of the sequences. In this paper, we focus on the complementary idea: how two sequences can be efficiently compared based on information that does not occur in the sequences. A word is an {\em absent word} of some sequence if it does not oc…

0301 basic medicineFOS: Computer and information sciencesFormal Languages and Automata Theory (cs.FL)Computer Science - Formal Languages and Automata TheorySequence alignmentInformation System0102 computer and information sciencesCircular wordAbsent words01 natural sciencesUpper and lower boundsSequence comparisonTheoretical Computer ScienceCombinatorics03 medical and health sciencesComputer Science - Data Structures and AlgorithmsData Structures and Algorithms (cs.DS)Absent wordCircular wordsMathematicsSequenceSettore INF/01 - InformaticaProcess (computing)q-gramComputer Science Applications1707 Computer Vision and Pattern Recognitionq-gramsComposition (combinatorics)Computer Science Applications030104 developmental biologyComputational Theory and MathematicsForbidden words010201 computation theory & mathematicsFocus (optics)Forbidden wordWord (computer architecture)Information SystemsInteger (computer science)
researchProduct